Breast pain and nodularity

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Mastalgia is classified by pattern before it is investigated: bilateral cyclical tenderness suggests hormonally responsive tissue, whereas movement-provoked pain suggests chest wall, shoulder or cervical origin. Focal breast inflammation, a discrete mass, pathological discharge, nipple change, skin distortion or abnormal nodes create a separate diagnostic concern. A dominant area that persists after surrounding nodularity changes must be assessed as a lump.

Breast pain alone is unlikely to be cancer and, whether generalised or focal, is not a routine indication for imaging under current RCR guidance. Management therefore starts with explanation, a supportive bra and a safe trial of analgesia, plus review of functional impact. Severe persistent pain can justify clinical review or specialist symptom care; imaging becomes appropriate when examination or another feature raises a distinct pathological concern.

Key points

Distinguish diffuse bilateral cyclical tenderness from a new focal persistent site, and separate background nodularity from a dominant mass.
Ask about menstrual timing, pregnancy, lactation, hormonal medicines, trauma, activity, bra support and pain reproduced by neck, shoulder or chest movement.
Examine both breasts and nodes, then palpate ribs, costochondral joints and pectoral structures when an extra-mammary source is possible.
Pain alone is unlikely to be breast cancer, but a hard mass, skin tethering, bloody discharge, nipple inversion or unexplained node changes the pathway.
For uncomplicated cyclical mastalgia, explanation, supportive fitting, simple analgesia and a symptom calendar can precede specialist drug treatment.
Do not request routine imaging for pain alone, whether generalised or focal. Image promptly when a separate mass, skin or nipple change, inflammation, node or other pathological clinical concern creates a diagnostic target.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Cyclical hormonal sensitivity

Breast stromal and glandular tissue can become tender and nodular with cyclical hormonal change, typically producing bilateral diffuse symptoms that rise before menstruation and ease afterwards.

Local and extra-mammary causes

Cysts, inflammation, trauma, large unsupported breasts, chest-wall strain, costochondral pain and referred cervical pain can produce focal discomfort; medicines and pregnancy may also change breast sensitivity.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Tissue tension and sensitivity
Cyclical stromal oedema and epithelial responsiveness can increase tissue tension and sensory input without creating a discrete pathological mass. Symptoms may vary markedly between cycles.
2
Inflammatory nociception
Infection, duct inflammation or fat injury releases inflammatory mediators and often creates focal tenderness, warmth or erythema; a collection adds pressure and may become fluctuant.
3
Chest-wall referral
Pain from ribs, costochondral joints, pectoral muscle or cervical nerves may be perceived within the breast. Reproduction by movement or focal chest-wall pressure supports this mechanism.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Cyclical pattern

Cyclical mastalgia is usually bilateral, diffuse and linked to the luteal phase, often with variable nodularity; a symptom calendar can establish timing better than retrospective recall.

Focal persistent pain

Localised non-cyclical pain deserves examination of the precise site and adjacent chest wall, especially when persistent or associated with a new mass or skin change.

Extra-mammary origin

Costochondral, pectoral, cervical radicular and cardiopulmonary pain may be perceived in the breast; reproducibility with movement or palpation can redirect the assessment.

Warning combinations

Pain alone is unlikely to represent cancer, but a hard fixed lump, unilateral nipple change, bloody discharge, peau d’orange or unexplained axillary node changes urgency.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Symptom and menstrual calendarFirst step
Why
Establish whether pain predictably varies with cycles, activity or support.
Interpretation and limitations
A two-cycle record may reveal a pattern, but must not delay referral when examination shows a concerning lesion or inflammatory change.
02
Focused breast and chest-wall examination
Why
Identify a discrete target, inflammation or reproducible musculoskeletal tenderness.
Interpretation and limitations
Diffuse nodularity is described by distribution and symmetry; a dominant mass remains a distinct finding requiring triple assessment.
03
Targeted breast imaging when a separate concern exists
Why
Evaluate a discrete mass, inflammatory change, pathological nipple feature or other abnormal finding that accompanies pain.
Interpretation and limitations
Pain alone, including focal pain, is not a routine imaging indication. The modality follows the separate target and age context rather than pain persistence by itself.
04
Pregnancy test or medication review
Why
Identify physiological or drug contributors when history supports them.
Interpretation and limitations
These assessments explain context but do not overrule a discrete abnormal examination; document hormonal treatments and medicines associated with breast tenderness.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Cyclical mastalgia

Bilateral diffuse discomfort linked consistently to menstruation, without a dominant lesion or warning feature, supports a hormonally patterned benign presentation.

Focal breast lesion

A cyst, fibroadenoma, inflammation, trauma-related fat necrosis or carcinoma can produce local pain. The palpable or imaging target requires its own diagnosis.

Extra-mammary pain

Costochondritis, muscle strain, radicular pain and occasionally cardiopulmonary disease can be described as breast pain; exertional or systemic features redirect urgency.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Worked case: integrated breast assessmentApply breast pain and nodularity to a defined presentationFirst stepA 31-year-old reports bilateral upper-outer breast tenderness before each period and general lumpiness that settles afterwards; examination finds no dominant mass or skin change.

1AlternativeConfirm cyclic timing, pregnancy possibility, medicine changes and absence of focal warning symptoms, then examine both breasts and the chest wall for a reproducible alternative source.
2Explain that bilateral cyclical pain with symmetrical nodularity and no dominant lesion is commonly benign, while defining the changes that would require renewed assessment.
3Offer supportive bra fitting and, if the adult weighs at least 50 kg with no relevant contraindication, paracetamol 500 mg to 1 g by mouth per dose at least four hours apart, up to four doses and no more than 4 g in 24 hours; reassess rather than continuing self-treatment beyond three days without advice.
4Arrange clinical follow-up if pain remains severe, impairs function or analgesia is ineffective. Do not order imaging for focality alone; image or refer when a mass, inflammatory change, nipple or skin feature, abnormal node or another pathological concern emerges.
5EscalationAt review, verify whether recorded timing and interventions altered symptoms rather than escalating treatment solely from continued anxiety.

02Pattern assessmentSeparate cyclical pain from a focal lesionBreast discomfort is present without an obvious emergency, and the patient reports variable lumpiness.

1Plot side, site, severity and menstrual relation, then ask whether one area remains distinct after surrounding nodularity settles.
2Examine after obtaining consent, comparing both breasts and checking for a dominant mass, discharge, inflammation, skin distortion and nodes.
3When the pattern is bilateral, cyclical and examination is benign, explain the likely mechanism and agree symptom measures plus a prospective diary.
4If a discrete mass, inflammatory change, pathological nipple feature, abnormal node or other clinical concern is found, request age-appropriate breast assessment. When pain is the only finding, manage symptoms and review rather than ordering routine imaging for focality alone.

03Refractory symptom pathwayReview pain that has not settledTwo menstrual cycles of conservative measures have not reduced function-limiting breast pain.

1Review the diary to confirm whether symptoms are truly cyclical and check adherence to bra support, analgesic limits and relevant medicine changes.
2Repeat focused breast, nodal and chest-wall examination at the original coordinates. Persistent pain alone does not mandate imaging, but any new discrete lesion, inflammatory feature or other pathological concern changes the diagnostic question.
3If examination remains benign, discuss referral for severe function-limiting symptoms and review the analgesic plan; avoid promising benefit from unproven supplements or using imaging as symptom treatment.
4Set a review point for response and adverse effects if any specialist treatment is started, with earlier return for a new lump or nipple or skin change.

Key medicines and prescribing safety1 treatment · regimens, roles and cautions

A first analgesic option for uncomplicated mastalgia while supportive fitting, explanation and clinical review address the symptom pattern.

Paracetamol

500 mg to 1 g by mouth per dose, at least 4 hours apart, up to four doses and a maximum of 4 g in 24 hours; without clinician advice, use for no longer than 3 days.

Check the dose with a clinician or pharmacist below 50 kg and in liver or kidney disease or regular excess alcohol use. Avoid simultaneous products containing paracetamol and seek urgent advice after overdose.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Delayed lump diagnosis

Attributing all tenderness to hormones can delay assessment when a persistent dominant mass, skin change or pathological discharge is present alongside pain.

Chronic functional burden

Persistent mastalgia can disturb sleep, activity, work, intimacy and breast awareness even when no dangerous disease is found; symptom impact merits specific management.

Investigation cascade

Untargeted imaging for diffuse pain may uncover incidental benign findings, prompting repeat tests and anxiety without explaining the original symptom.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Use a daily pain-and-cycle record for at least one complete cycle when cyclical mastalgia is suspected, capturing side and focality rather than only severity.
At follow-up, compare whether bra support, activity modification or simple analgesia changed sleep, work and exercise, not merely the numerical pain score.
Re-examine any site that becomes persistently focal and document whether a dominant mass or inflammatory change has emerged.
Stop routine follow-up after sustained improvement only when the person understands which new lump, discharge, inversion, skin change or node warrants reassessment.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Nodularity is a pattern, not a shield

Symmetrical mobile texture can be physiological, yet a dominant area that persists through the cycle should be mapped and assessed as a separate lump.

Chest-wall examination adds value

Pain reproduced over a rib or with resisted movement can spare unnecessary breast intervention while directing musculoskeletal care, provided the breast examination is adequate.

Expectation affects adherence

Explaining that benign mastalgia may fluctuate helps patients judge gradual improvement. An absolute promise of cure can make normal recurrence feel like missed disease.

Escalation should match impact

Specialist therapies can have meaningful adverse effects and belong after diagnosis, conservative measures and assessment of functional burden rather than as routine initial treatment.

11Common pitfallsFrequent interpretation and management errors.

01
Assuming every premenstrual pain is benign without examining the breast can miss a coexisting dominant mass.
02
Repeatedly squeezing or palpating a tender area can perpetuate soreness and make interval comparison harder.
03
Ordering untargeted imaging for diffuse cyclical pain may create incidental findings while failing to address the symptom mechanism.
04
Using tenderness to rule out cancer is unsafe because significant lesions can be painful as well as painless.

Find your next topic